MorphoSys receives FDA approval for Monjuvi for diffuse large B-cell lymphoma Aug. 3, 2020 No Comments
FDA approves Tecentriq with Cotellic and Zelboraf for BRAF V600 mutation-positive advanced melanoma July 31, 2020 No Comments
Tecartus wins accelerated approval from FDA for relapsed or refractory mantle cell lymphoma July 27, 2020 No Comments
Alzumab approved in India for emergency use to treat CRS in patients with COVID-19-related ARDS July 13, 2020 No Comments
FDA approves Byfavo injection for the induction and maintenance of procedural sedation July 3, 2020 No Comments
FDA approves Rukobia for the treatment of adults with multidrug-resistant HIV-1 infection July 3, 2020 No Comments
RSS